0 projects

Selections based on text queries do not reflect the Research Council's published statistics. Read more...


Text queries provide an overview of all projects containing the specified text in either its title or summary. This may result in a different selection of projects than that used by the Research Council as presented in its various publications. The Research Council's statistics are normally based on selections in set categories. You will find these in the left menu, in the diagrams themselves or when selecting from the left column of autocomplete suggestions via the search field.

Les mer...

PES2020-Prosj.etabl.støtte H2020

ARCHER: Antimicrobial coated bReakaway variable lumen Connector for intravenous tHERapy

The overall aim of the ARCHER project is to develop the first antimicrobial impregnated breakaway connection device that prevents central line associated blood stream infections in patients undergoing central venous catheter intravenous (IV) therapy, decreasing healthcare expenses, and reducing p...

Awarded: NOK 79,999

Project Period: 2021-2021

Location: Ukjent Fylke

PES2020-Prosj.etabl.støtte H2020

Late pre-clinical and Phase 1a studies for a promising drug lead that may drastically improve cognition in individuals with Down Syndrome.

Currently, there are no approved treatments for the primary symptoms of DS, and only limited treatments for dementia in ageing individuals. Dual-specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) is an essential factor in Down Syndrom. DYRK1A regulates differentiation of neuronal ...

Awarded: NOK 74,999

Project Period: 2018-2018

Location: Ukjent Fylke

BIA-Brukerstyrt innovasjonsarena

A novel antimicrobial agent for treatment of infections caused by drug-resistant bacteria, preclinical and early phase clinical studie

The present proposal covers preclinical exploratory and Phase I/IIa development programme of LTX-109. The proposal encompasses our internal development program as well as the establishment and management of external production and development programs. L ytix Biopharma AS develop novel antimicro...

Awarded: NOK 12.1 mill.

Project Period: 2009-2011

Location: Ukjent Fylke